References and Further Reading:
Cranton EM, Frackelton JP. Free radical pathology in age-associated diseases: treatment with EDTA chelation, nutrition, and antioxidants. J Hol Med. 1984;6:6-37.
Gutteridge JMC. Ferrous-salt-promoted damage to deoxyribose and benzoate, the increased effectiveness of hydroxyl-radical scavengers in the presence of EDTA. Biochem J. 1987; 243: 709-714.
Deucher DP. EDTA Chelation Therapy: an antioxidant strategy. J Adv in Med. 1988;1:182-190.
Bjorksten J. Possibilities and limitations of chelation as a means for life extension. J Adv in Med. 1989;2:77-78.
Lamb DJ, Leake DS. The effect of EDTA on the oxidation of low density lipoprotein. Atherosclerosis. 1992; 94:35-42.
Rahko PS, Salerni R, Uretsky BF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Card. 1986;9:436-40.
Menasche P, Pinwica A. Free radicals and myocardial protection: a surgical viewpoint. Ann Thorac Surg. 1989;47:939-45.
Rudolph CJ, McDonagh EW, Barber RK. Effect of EDTA chelation on serum iron. J Adv in Med. 1991;4:39-45.
Gordon GB, Vance RB. EDTA chelation therapy for atherosclerosis: history and mechanism of action. Ost Ann. 1976;4:38-62.
Halstead BM. The scientific basis of EDTA chelation therapy. Colton, California, Golden Quill Publishers 1979.
Kaman RL, Rudolph CJ, McDonagh EW, Walker FM. Effect of EDTA chelation therapy on aortic calcium in rabbits on atherogenic diets: quantitative and histochemical studies. J Adv in Med. 1990;3:13-22.
Levy RJ, Howard SL, Oshry LJ. Carboxyglutamic acid (Gla) containing proteins of human calcified atherosclerotic plaque solubilized by EDTA: molecular weight distribution and relationship to osteocalcin. Atherosclerosis. 1986;59:155-60.
Walker FM, Wilson CW III, Kaman RL. The effects of EDTA chelation therapy on plaque calcium and plasma lipoproteins in atheroscelrotic rabbits. Fed Proc. 1979;38 (No. 4335).
Walker FM, Wilson CW III, Kaman RL. The effects of EDTA chelation therapy on plaque composition and serum lipoproteins in atherosclerotic rabbits. J Am Ost Assoc. 1978;78:144.
Kindness G, Frackelton JP. Effect of ethylene diamine tetraacetic acid (EDTA) on platelet aggregation in human blood. J Adv in Med. 1989;2:519-30.
Perizzolo KE, Sullivan S, Waugh DF. Effects of calcium binding nad of EDTA and CaEDTA on the clotting of bovine fibrinogen by thrombin. Arch Biochem Biophys. 1985;237:520-534.
Gordon GB, Vance RB. EDTA chelation therapy for atherosclerosis: history and mechanism of action. Ost Ann. 1976;4:38-62.
Altura BM, Altura BT. Magnesium withdrawal and contraction of arterial smooth muscle: effects of EDTA and EGTA, and divalent cations. Proc Soc Exp Biol Med. 1976;151:752-755.
Cranton EM, Frackelton JP. Current status of EDTA chelation therapy on occlusive arterial disease. J Adv in Med. 1989;2:107-119.
Cranton EM, Frackelton JP. Free oxygen radical pathology and EDTA chelation therapy: mechanisms of action. J Adv in Med. 1998;11(4):277-310.
Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, Vita JA. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001 Jun 12;103(23):2799-804.